BIPTRM
Karachi, Sindh, Pakistan
NCT Number: NCT06766877
Knee osteoarthritis (KOA) is a degenerative joint disease causing pain, stiffness, and reduced quality of life. While treatments often focus on drugs or surgery, noninvasive exercises like core stabilization and ankle/foot strengthening show potential but lack comparative studies. Understanding anatomical factors like Achilles tendon (AT) thickness is crucial for targeted rehabilitation, though measurement reliability remains an issue. This study aims to compare the effects of these exercises on KOA symptoms and evaluate the use of digital calipers for AT thickness measurement, aiming to enhance clinical management of KOA.
Interested in participating?
Request Info40 year and older
All sexes
Interventional
Not applicable
Karachi, Sindh, Pakistan
The objective of the study is:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 weeks
Changes from baseline, KOOS score consist of five patient-relevant dimensions that are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included. This scale consist of total 42-items and score of this scale range from 0 (severe knee pathology) to 100 (no knee problem). This tool has been use to assess the pain, symptoms, activities level, function in knee osteoarthritis patients. It is a valid tool for Knee Osteoarthritis patients ; validity ranges up-to (0.80-0.89).
Time frame: 8 weeks
Changes from baseline, Visual Analogue Scale (VAS) is the most commonly used scale in which the pain rate ranges from 0 (no pain) to 10 (worst pain). The level of knee perception of pain is assessed by using the VAS.
Time frame: 8 weeks
change from baseline, time taken to ascend and descend the stairs
Time frame: 8 weeks
Change from baseline, flexion was assessed with a goniometer
Time frame: 8 weeks
change from baseline, extension was assessed with goniometer
Time frame: 8 weeks
Change from baseline, tendon thickness was measured was assessed with digital calliper
Time frame: 8 weeks
change from baseline, The 30 Second Sit to Stand Test is also known as 30 Second Chair Stand Test (30CST), was initially designed for testing leg strength and endurance in older adults.
Time frame: 8 weeks
The Timed Up and Go Test (TUG) assesses mobility, balance, walking ability, and fall risk in older adults
Time frame: 8 weeks
Instruct patient to walk as quickly, but as safely as possible, without running, along 10m walkway, past the taped line, & then turn around cone & return.
Time frame: 8 weeks
Patient to perform plantar flexion in the form of single-limb heel raise
Time frame: 8 weeks
The midfoot alignment was assessed using the navicular/foot ratio, which is calculated as the ratio of the navicular height to the total foot length.
Time frame: 8 weeks
The dorsiflexion range of ankle movement was evaluated using the knee-to-wall lunge technique
Dow University of Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04653896
Arthritis, Joint Diseases
The Bronx, New York, United States
View Trial DetailsNCT06000410
Arthritis, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03294408
Arthritis, Joint Disease
Nancy, France
View Trial DetailsNCT05618782
Arthritis, Connective Tissue Diseases
Brno, Czechia
View Trial Details